Skip to main content
ANIX logo

Anixa Biosciences, Inc.

ANIXNASDAQHealthcareBiotechnology

$2.93Today:- (-)1Y −33.49%

As of Oct 26, 2026 close

Market cap
$100.15M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.32$5.46
Volume (live)
-
Avg. volume (3M)
279.48K

Anixa Biosciences (ANIX) Balance Sheet

As of Oct 31, 2025 (end of fiscal 2025), Anixa Biosciences reported total assets of $16.08M and total liabilities of $2.13M. Shareholders' equity was $15.16M, down 24.2% from $20.00M a year earlier. Total debt stood at $204.00K against $15.17M in cash and short-term investments, a net cash position of $14.97M. That puts debt-to-equity at 0.01, compared with 0.01 a year earlier.

Anixa Biosciences Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Anixa Biosciences, Inc. (ANIX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingOct 2025Oct 2024Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017
Current Assets
Cash and Cash Equivalents1.241.270.9212.3629.136.423.493.063.34
Short-Term Investments13.9318.6522.9317.336.602.642.352.003.50
Cash & Short-Term Investments15.1719.9223.8429.6935.739.065.845.066.84
Accounts Receivable0.000.170.270.050.000.000.070.310.00
Inventory0.000.000.00-0.050.000.00-2.350.000.00
Other Current Assets0.711.271.240.470.280.310.180.180.17
Total Current Assets15.8921.3625.3630.2036.009.376.095.547.01
Non-Current Assets
Property, Plant & Equipment (Net)0.190.230.170.210.250.050.200.070.05
Intangible Assets0.000.000.000.000.000.000.000.841.75
Other Non-Current Assets0.000.000.000.000.000.030.000.000.00
Total Non-Current Assets0.190.230.170.210.250.080.200.911.80
Total Assets16.0821.5925.5230.4136.269.456.296.458.81
Current Liabilities
Accounts Payable0.170.530.210.270.140.230.590.580.48
Short-Term Debt0.040.030.050.050.040.060.000.000.00
Accrued Liabilities1.761.951.771.731.10----
Other Current Liabilities1.761.951.771.731.100.900.900.680.41
Total Current Liabilities1.972.502.032.041.271.191.481.270.89
Non-Current Liabilities
Long-Term Debt0.160.200.120.180.220.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.000.000.000.000.00
Total Non-Current Liabilities0.160.200.120.180.220.000.000.580.48
Total Liabilities2.132.702.152.211.491.191.481.270.89
Stockholders' Equity
Common Stock0.330.320.310.310.300.240.200.190.17
Retained Earnings-251.68-240.75-228.20-218.39-204.79-191.84-181.82-170.17-156.17
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.000.00-0.04
Treasury Stock-0.01-------
Additional Paid-in Capital266.51260.43252.22247.12239.93200.35186.85175.42163.93
Minority Interest-1.21-1.11-0.97-0.85-0.67-0.50-0.42-0.250.00
Shares Outstanding33.0132.2031.1530.91-----
Total Stockholders' Equity15.1620.0024.3428.2035.448.765.245.437.92
Total Liabilities & Equity16.0821.5925.5230.4136.269.456.296.458.81

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Anixa Biosciences Balance Sheet

How much debt does Anixa Biosciences have?

Anixa Biosciences had total debt of $204.00K as of Oct 31, 2025, against $15.17M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $232.00K a year earlier.

What are Anixa Biosciences's total assets?

Anixa Biosciences reported total assets of $16.08M as of Oct 31, 2025, down 25.5% from $21.59M a year earlier. Total liabilities were $2.13M.

What is Anixa Biosciences's shareholders' equity?

Anixa Biosciences's shareholders' equity was $15.16M as of Oct 31, 2025, or about $0.46 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition